High dose antioxidant supplementation to MS patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
High-dose antioxidant supplementation has recently been recommended for multiple sclerosis (MS) patients. This study tests the clinical safety, the glutathione peroxidase (GSH-px) activity, and the absorption of selenium during such supplementation. Eighteen MS patients were given 6 tablets especially made for this study, equivalent to 6 mg sodium selenite, 2 g vitamin C, and 480 mg vitamin E a day for five wk. GSH-px, which was lower than in non-MS controls before the start of treatment, increased fivefold during 5 wk of treatment. Side effects were scarce. Ten MS patients were subjected to a 24-h selenium absorption study after ingestion of 2 active tablets, equivalent to 2 mg sodium selenite. Selenium, which was low initially, increased 24% during the first 3 h and then stabilized. It is concluded that the tested antioxidant treatment seems to be safe and that MS patients have low GSH-px, which may be increased by the tested antioxidant treatment.
- H. S. Mickel,Perspect. Biol. Med. 18, 363 (1975).
- F. Carmagnol, P. M. Sinet, and H. Jerome,Biochem. Biophys. Acta 759, 49 (1983).
- M. I. S. Hunter, B. C. Nlemadim, and D. L. W. Davidson,Neurochem. Res. 10, 1645 (1985). CrossRef
- J. Wikström, T. Westermarck, and J. Palo,Acta Neurol. Scand. 54, 287 (1976). CrossRef
- R. C. Dicson and R. H. Tomilson,Clin. Chem. Acta 16, 311 (1967). CrossRef
- National Academy of Science, National Research Council: Recommended dietary allowances. Nat. Acad. Sci., Washington, DC, 1980.
- G. E. Jensen, G. Gissel-Nielsen, and J. Clausen,J. Neurol. Sci. 48, 61 (1980). CrossRef
- G. E. Jensen and J. Clausen,J. Neurol. Sci. 63, 45 (1984). CrossRef
- G. E. Jensen and J. Clausen,Acta Pharmacol. Toxicol. 59, suppl. 7, 450 (1986).
- D. McAlpine, C. E. Lumsden, and E. D. Acheson,Multiple Sclerosis, a Reappraisal, 2nd ed., pp. 81–307, Churchill-Livingstone, Edinburgh, 1972.
- J. Mai,Sclerosen 4, 8 (1985).
- J. F. Kurtzke,Neurology (Cleveland) 33, 1444 (1983).
- B. E. Paglia and W. N. Valentine,J. Lab. Clin. Med. 70, 158 (1967).
- G. E. Jensen, V. K. S. Shukla, G. Gissel-Nielsen, and J. Clausen,Scand. J. Clin. Lab. Invest. 38, 309 (1978). CrossRef
- J. C. Hansen, K. Overvad, U. Tarp, and E. B. Thorling,Ugeskr. Læg. 147, 1911 (1985).
- G. Yang, S. Wang, R. Zhou, and S. Sun,Clin. Nutr. 37, 872 (1983).
- C. D. Thomson, C. E. Burton, and M. F. Robinson,Br. J. Nutr. 39, 579 (1978). CrossRef
- H. M. Mykkänen and M. L. Mutanen,Nutr. Rep. Int. 28, 67 (1983).
- F. M. Robinson, C. D. Thomson, and P. K. Huemmer,NZ Med. J. 98, 627 (1985).
- M-T. Lo and E. Sandi,J. Env. Pathol. Toxicol. 4, 193 (1980).
- G. E. Jensen, Ph.D. Thesis, Institute of Biology and Chemistry, University of Roskilde, Denmark, 1988.
- High dose antioxidant supplementation to MS patients
Biological Trace Element Research
Volume 24, Issue 2-3 , pp 109-117
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press
- Additional Links
- Multiple sclerosis
- sodium selenite
- vitamin C
- vitamin E
- Industry Sectors